BIT biotron limited

0.00%

0.2¢

No regulator will pull them up unless it’s reported No Class...

First 5 Last

Share
Profile

Follow
Tanybryn

288 Posts.

100

23/01/25

18:59

Post #: 77536705
Share

Originally posted by a2zz: ↑

Some regulatory oversights or polcing are missing particularly in the case of small biotech like Biotron where the CEO and BOD are not functioning at all.
Their Silence work better from them. As soon as they update something, the SHs/market gets infuriated about their updates.
Their Silence is not at all interrupting their regular salary.
Let this drama come to the end either by selling the company in the form of acquisition or getting it delisted and having the CEO and the BOD behind the bars and having their assets confiscated for misguding the SHs and the tax payers and the Govt...

If nothing get acquired, it means they're with bogus things to trick the SHs and the tax payers into giving them money for luxury.

Dicussion going on that Michelle had been tellign and writing should be disclosed in relation to the C14. Let the Biotron and C14 ceos update the market about what they are doing and what they upto and where they want to go from where they now in, and how long will it take, and what will be overall expenses... If nothing is made clear, no one is going to put a cent into the company.

Theis fitness certiticate means they need to make the new and existing SHs attracted tot he company in the form of takign the SP at 18cps and announcing CR at 13cps. If there is no fitness certificate in the coming months, the company is apparently dead and dust. I'm holding to see the end of the corporate mockery and tricks.

Expand

No regulator will pull them up unless it’s reported

No Class Action will start without it being initiated

I know that in many instances it takes multiple individuals to complain or initiate for action to be taken

I have run hard trying and I hope others are doing the same

Let’s collectively drain their superannuation and assets through fines and penalties…..

BIT Price at posting: 1.7¢ Sentiment: Hold Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.2¢		Change 0.000(0.00%)		Mkt cap ! $2.654M

Open	High	Low	Value	Volume
0.2¢	0.2¢	0.2¢	$210	104.8K

Buyers (Bids)

No.	Vol.	Price($)
64	38848316	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	18281126	25

View Market Depth

No.	Vol.	Price($)
59	37148316	0.002
33	65631001	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	14162401	23
0.004	12820969	17
0.005	6684000	5
0.006	1200000	2
0.007	1084188	2

Last trade - 12.28pm 27/06/2025 (20 minute delay)

BIT (ASX) Chart

No regulator will pull them up unless it’s reported No Class...

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

No regulator will pull them up unless it’s reported No Class...

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News